Concentra Group Holdings Parent, Inc. (NYSE: CON), a leader in occupational health services with a market capitalization of $2.84 billion, has announced preliminary financial results for the fourth ...
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CON stock, giving a Buy rating yesterday.Invest with Confidence: ...
Nova Biomedical develops and manufactures medical devices and diagnostics equipment that can be used by health-care providers for advanced blood testing and analysis, according to its website.
Concentra Announces Preliminary 2024 Financial Results, Agreement To Acquire Nova Medical Centers, and 2025 Financial Guidance ...